• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Adapthealth Signs Definitive Agreement to Acquire Patient Care Solutions Business from Mckesson Corporation

Share:

December 2, 2019

AdaptHealth Corp. (NASDAQ: AHCO; AHCOW) (“AdaptHealth” or the “Company”), the third largest home medical equipment (HME) provider in the United States, today announced it has entered into a definitive agreement to acquire the Patient Care Solutions (PCS) business from McKesson Corporation. The proposed transaction is expected to close in December 2019, subject to the satisfaction of customary closing conditions. The total investment, including restructuring costs until the business is fully integrated on AdaptHealth’s platform in the latter half of 2020, is expected to be approximately $30 million.

PCS currently provides wound care supplies, ostomy supplies, urological supplies, incontinence supplies, diabetic care supplies, and breast pumps directly to patients across the United States. The company maintains extensive national relationships with physicians, medical facilities and customers, and currently serves all 50 states.

For the trailing twelve months ended October 31, 2019, PCS generated net revenues of approximately $134 million. In connection with the acquisition, AdaptHealth will enter into a supply and distribution agreement with McKesson Corporation with respect to PCS’s HME service lines.

“The acquisition of PCS will, upon closing, represent an important step in our continuing growth as an industry consolidator,” said Luke McGee, AdaptHealth’s CEO. “In addition to adding scale and strengthening our geographic footprint, we will add urological and ostomy products to our already comprehensive HME product portfolio, and significantly increase our exposure in areas such as wound care, breast pumps, incontinence supplies, and diabetic care. We believe the addition of these products will double our overall addressable market.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Josh Parnes, President and COO of AdaptHealth added, “As part of the transaction, we are also very pleased to expand our existing distribution relationship with McKesson. The acquisition of PCS complements our existing PAP (sleep) resupply offering and will allow us to provide an expanded set of supplies to both the current customers of PCS and AdaptHealth.”

Source: Business Wire

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Genome Medical Raises $14M in FundingGenome Medical Raises $14M in Funding
  • Altasciences Completes Acquisition of Preclinical Testing Business and Hires Key StaffAltasciences Completes Acquisition of Preclinical Testing Business and Hires Key Staff
  • Roche Delays Spark Buyout Again as U.S. and U.K. Regulators Continue to Review The DealRoche Delays Spark Buyout Again as U.S. and U.K. Regulators Continue to Review The Deal
  • COVID-19: XRHealth Launches Virtual Reality Telehealth Supports GroupsCOVID-19: XRHealth Launches Virtual Reality Telehealth Supports Groups
  • Aptar Acquires Nanopharm and Gateway Analytical, Broadening Pharma Services Platform to Accelerate Customer Drug DevelopmentAptar Acquires Nanopharm and Gateway Analytical, Broadening Pharma Services Platform to Accelerate Customer Drug Development
  • Taiwanese Mobile Health Firm Ixensor Introduces Telehealth Service Assisting At-Home Fertility MonitoringTaiwanese Mobile Health Firm Ixensor Introduces Telehealth Service Assisting At-Home Fertility Monitoring
  • Sibel Health announces new monitoring tool, partnership with MedidataSibel Health announces new monitoring tool, partnership with Medidata
  • First patient cells were collected in XNK’s preclinical bladder cancer study.First patient cells were collected in XNK’s preclinical bladder cancer study.

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications